Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality.

Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality. J Urol. 2012 Jun; 187(6):2068-73.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.